Regeneron Pharmaceuticals (REGN) EBT Margin (2009 - 2026)
Regeneron Pharmaceuticals' quarterly EBT Margin came in at 23.05% in Q1 2026, down 683.0% year-on-year from 3.95% in Q1 2025, and down 14.2% quarter-over-quarter from 26.87% in Q4 2025.
Regeneron Pharmaceuticals has reported EBT Margin for 18 years, with the latest figure at 23.05% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 683.0% year-over-year to 23.05%; the trailing twelve-month figure through Mar 2026 stood at 34.56% (down 82.0% YoY), and the FY2025 full-year result was 36.47%, up 281.0% from the prior year.
- EBT Margin for Q1 2026 stood at 23.05%, down from 26.87% in the prior quarter.
- The five-year high for EBT Margin was 2122.2% in Q1 2022, with the low at 22.28% in Q1 2024.
- Average EBT Margin over 5 years is 233.03%, with a median of 33.71% recorded in 2022.
- Year-over-year, EBT Margin surged 207265 bps in 2022 and slumped 209507 bps in 2023.
- Tracing REGN's EBT Margin over 5 years: stood at 1324.7% in 2022, then sank by 97 bps to 33.42% in 2023, then declined by 24 bps to 25.29% in 2024, then gained by 6 bps to 26.87% in 2025, then declined by 14 bps to 23.05% in 2026.
- The last three EBT Margin figures came in at 23.05% (Q1 2026), 26.87% (Q4 2025), and 46.97% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 18.99% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.05% |
| Dec 31, 2025 | 26.87% |
| Sep 30, 2025 | 46.97% |
| Jun 30, 2025 | 41.32% |
| Mar 31, 2025 | 29.88% |
| Dec 31, 2024 | 25.29% |
| Sep 30, 2024 | 40.13% |
| Jun 30, 2024 | 45.90% |
| Mar 31, 2024 | 22.28% |
| Dec 31, 2023 | 33.42% |
| Sep 30, 2023 | 33.03% |
| Jun 30, 2023 | 34.29% |
| Mar 31, 2023 | 27.13% |
| Dec 31, 2022 | 1,324.70% |
| Sep 30, 2022 | 51.42% |
| Jun 30, 2022 | 33.71% |
| Mar 31, 2022 | 2,122.20% |
| Dec 31, 2021 | 50.56% |
| Sep 30, 2021 | 52.61% |
| Jun 30, 2021 | 73.03% |
| Mar 31, 2021 | 49.55% |
| Dec 31, 2020 | 50.54% |
| Sep 30, 2020 | 43.52% |
| Jun 30, 2020 | 47.07% |
| Mar 31, 2020 | 36.57% |
| Dec 31, 2019 | 47.75% |
| Sep 30, 2019 | 44.07% |
| Jun 30, 2019 | 14.24% |
| Mar 31, 2019 | 39.79% |
| Dec 31, 2018 | 35.08% |
| Sep 30, 2018 | 38.23% |
| Jun 30, 2018 | 40.80% |
| Mar 31, 2018 | 38.73% |
| Dec 31, 2017 | 35.06% |
| Sep 30, 2017 | 37.69% |
| Jun 30, 2017 | 35.77% |
| Mar 31, 2017 | 32.77% |
| Dec 31, 2016 | 27.84% |
| Sep 30, 2016 | 29.99% |
| Jun 30, 2016 | 24.10% |
| Mar 31, 2016 | 27.49% |
| Dec 31, 2015 | 20.70% |
| Sep 30, 2015 | 34.58% |
| Jun 30, 2015 | 32.85% |
| Mar 31, 2015 | 31.80% |
| Dec 31, 2014 | -3.93% |
| Sep 30, 2014 | 25.05% |
| Jun 30, 2014 | 31.37% |
| Mar 31, 2014 | 28.91% |
| Dec 31, 2013 | 29.68% |
| Sep 30, 2013 | 37.80% |
| Jun 30, 2013 | 32.27% |
| Mar 31, 2013 | 32.26% |
| Dec 31, 2012 | 32.45% |
| Sep 30, 2012 | 44.77% |
| Jun 30, 2012 | 25.21% |
| Mar 31, 2012 | 5.03% |
| Dec 31, 2011 | -43.96% |
| Sep 30, 2011 | -60.10% |
| Jun 30, 2011 | -58.78% |
| Mar 31, 2011 | -38.91% |
| Dec 31, 2010 | 111.94% |
| Sep 30, 2010 | -686.28% |
| Jun 30, 2010 | -21.98% |
| Mar 31, 2010 | -1,618.35% |
| Dec 31, 2009 | -309.18% |
| Sep 30, 2009 | -0.86% |
| Jun 30, 2009 | -331.96% |